GQG Partners’s AbbVie ABBV Stock Holding History

GQG Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$484M	Buy	+1,921,614	New	+$413M	0.9%	31
2023 Q2	–	Sell	-46,487	Closed	-$7.41M	–	69
2023 Q1	$7.41M	Buy	46,487 +2,507	+6%	+$383K	0.02%	55
2022 Q4	$7.11M	Sell	43,980 -429	-1%	-$65.8K	0.02%	60
2022 Q3	$5.96M	Sell	44,409 -3,007,211	-99%	-$432M	0.02%	57
2022 Q2	$468M	Buy	3,051,620 +2,882,655	+1,706%	+$440M	1.15%	29
2022 Q1	$27.4M	Buy	168,965 +131,780	+354%	+$19.1M	0.06%	47
2021 Q4	$5.03M	Buy	37,185 +25,358	+214%	+$3M	0.01%	57
2021 Q3	$1.28M	Buy	11,827 +3,354	+40%	+$383K	﹤0.01%	57
2021 Q2	$954K	Sell	8,473 -3,105,796	-100%	-$350M	﹤0.01%	59
2021 Q1	$337M	Sell	3,114,269 -104,339	-3%	-$11.2M	1.23%	32
2020 Q4	$345M	Buy	+3,218,608	New	+$309M	1.18%	30

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

GQG Partners's ABBV Position: Q2 2026 in Review

GQG Partners opened a new position in AbbVie (ABBV) in Q2 2026: 1,921,614 shares worth $484M. The stake represents 0.9% of the portfolio and ranks #31 among its holdings. This is a return to the name: GQG Partners previously reported a position in ABBV as recently as Q1 2023.

GQG Partners first reported a position in ABBV in Q4 2020 and has held it in 11 quarters since. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

GQG Partners held 1,921,614 shares of AbbVie worth $484M as of Q2 2026.
AbbVie was a new GQG Partners position in Q2 2026.
AbbVie made up 0.9% of GQG Partners's portfolio in Q2 2026, its #31 holding.
GQG Partners first reported a position in AbbVie in Q4 2020 and has held it in 11 quarters since.
4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on GQG Partners's 13F filing for Q2 2026, filed 12 Aug 2026.